目的 确定黄疸新生儿接受光疗期间经皮胆红素测量(TcB)与血清总胆红素测量结果(TSB)的一致性,为黄疸患儿光疗期间胆红素检测的方法选择提供依据。方法 2017年3月-2018年5月采用前瞻性的研究设计,连续纳入需要接受光疗和TSB测量的足月新生儿。光疗开始前和光疗期间分别测量TSB,并在测量TSB完成后的3 min内测量患儿TcB值。采用Bland-Altman分析TcB和TSB的一致性。结果 共纳入患儿239例,平均胎龄为(38.3±1.2)周,平均出生体重为(3.1±0.23) kg。在光疗开始前TSB和TcB分别为(221.3±32.8)μmol/L和(227.5±33.9)μmol/L;光疗期间分别为(188.6±35.2)μmol/L和(185.9±32.6) μmol/L。Bland-Altman分析显示,在光疗开始前TcB和TSB的均数差为(6.7±21.4)μmol/L(95%CI:-27.9~41.2 μmol/L);光疗期间为(-2.7±20.7) μmol/L(95%CI:-42.4~37.1 μmol/L)。结论 黄疸足月儿TcB和TSB的一致性较好,可用于光疗期间胆红素水平的监测。
Abstract
Objective To determine whether transcutaneous bilirubin measurements(TcB) before and during phototherapy consist with total serum bilirubin(TSB) levels,in order to provide reference for the bilirubin monitoring during phototherapy. Methods A prospective observational study was conducted on full-term neonates requiring phototherapy and TSB measurements from March 2017 to May 2018.TcB measurement was collected within 3 minutes of blood for TSB measurements.The consistency of TcB and TSB was analyzed by Bland-Altman method. Results A total of 239 neonates were included,with the gestational age of (38.3±1.2) weeks and birth weight of (3.1±0.23)kg.Before starting phototherapy,the levels of TSB and TcB were (221.3±32.8) μmol/L and (227.5±33.9)μmol/L,respectively.During phototherapy,the levels of TSB and TcB were (188.6±35.2) μmol/L and (185.9±32.6) μmol/L,respectively.The Bland-Altman analysis demonstrated that before starting phototherapy the mean difference between TSB and TcB was (6.7±21.4) μmol/L (95% CI:-27.9-41.2)μmol/L,which was(-2.7±20.7)μmol/L (95% CI:-42.4-37.1)μmol/L during phototherapy. Conclusion The consistency between TcB measurement and TSB measurement is satisfying,indicating that both of them can be used to monitor bilirubin levels during phototherapy in jaundiced term infants.
关键词
新生儿 /
黄疸 /
光疗 /
胆红素
Key words
neonate /
jaundice /
phototherapy /
bilirubin
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 中华医学会儿科学分会新生儿学组,《中华儿科杂志》编辑委员会.新生儿高胆红素血症诊断和治疗专家共识[J].中华儿科杂志,2014,65(10):745-748.
[2] 孙立平,王助衡,底建辉,等.足月显性黄疸新生儿TcB与血清TSB测定的比较[J].中国妇幼健康研究,2016,27(7):789-791,795.
[3] 李秋平,封志纯.美国儿科学会最新新生儿黄疸诊疗指南[J].实用儿科临床杂志,2006,21(14):958-960.
[4] Bland JM,Altman DG.Statistical methods for assessing agreement between two methods of clinical measurement [J].Lancet,1986,1(8476):307-310.
[5] 葛敏,唐军.新生儿重症高胆红素血症治疗进展[J].中华妇幼临床医学杂志:电子版,2018,14(3):360-367.
[6] 刘甜甜,钟伟华,陆梦洁,等.2014~2016年中国Bland-Altman方法一致性评价的报告质量研究[J].中国循证医学杂志,2018,18(1):67-73.
[7] Reyes CA,Stednitz DR,Hahn C,et al.Evaluation of the BiliChek being used on hyperbilirubinemic newborns undergoing home phototherapy[J].Arch Pathol Lab Med,2018,132(4):684-689.
[8] Karon BS,Teske A,Santrach PJ,et al.Evaluation of the BiliChek non-invasive bilirubin analyzer for prediction of serum bilirubin and risk of hyperbilirubinemia[J].Am J Clin Pathol,2017,130:976-982.
[9] Campbell DM,Danayan KC,McGovern V,et al.Transcutaneous bilirubin measurement at the time of hospital discharge in a multiethnic newborn population[J].Paediatr Child Health,2011,16:141-145.